PRCM
WINT

Pine River Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Pine River Capital Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,286
Closed – – 855
2015
Q4 		$0 Hold
14,286
– – ﹤0.01% 802
2015
Q3 		$0 Hold
14,286
– – ﹤0.01% 784
2015
Q2 		$0 Hold
14,286
– – ﹤0.01% 836
2015
Q1 		$8K Buy
+14,286
New +$281K ﹤0.01% 591
2014
Q4 		– Sell
-14,286
Closed -$85K – 1057
2014
Q3 		$85K Hold
14,286
– – ﹤0.01% 946
2014
Q2 		$77K Buy
+14,286
New +$365K ﹤0.01% 676
2014
Q1 		– Sell
-14,286
Closed -$166K – 803
2013
Q4 		$166K Buy
+14,286
New +$447K ﹤0.01% 613

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pine River Capital Management's WINT Position: Q1 2016 in Review

Pine River Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 14,286 shares.

Pine River Capital Management first reported a position in WINT in Q4 2013 and held it in 7 quarters. The position peaked at $166K in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Pine River Capital Management reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Pine River Capital Management sold 14,286 Windtree Therapeutics Inc shares in Q1 2016.
  • Pine River Capital Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 7 quarters.
  • Pine River Capital Management's Windtree Therapeutics Inc position peaked at $166K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.